17 October 2024NewsCareersMuireann Bolger

PierFerd adds AI patent partner with ‘dynamic experience’

Former patent examiner and federal clerk brings expertise in cutting-edge biomedical tech to the US firm.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Jones Day hires pharma and high-tech patent litigator to London office

15 October 2024 Global law firm recruits former CMS partner to IP practice I Patent lawyer brings expertise in pharmaceuticals, tech and AI

Powell Gilbert co-founder moves to US firm

14 October 2024 US firm doubles down in Europe with another big name recruit | Tech and life sciences litigation at the UPC a target | Powell will 'always be a friend of the firm’ says ex-colleague Penny Gilbert | Move ends speculation about Powell’s future after August resignation.

More on this story

Jones Day hires pharma and high-tech patent litigator to London office

15 October 2024 Global law firm recruits former CMS partner to IP practice I Patent lawyer brings expertise in pharmaceuticals, tech and AI

Powell Gilbert co-founder moves to US firm

14 October 2024 US firm doubles down in Europe with another big name recruit | Tech and life sciences litigation at the UPC a target | Powell will 'always be a friend of the firm’ says ex-colleague Penny Gilbert | Move ends speculation about Powell’s future after August resignation.

More on this story

Jones Day hires pharma and high-tech patent litigator to London office

15 October 2024 Global law firm recruits former CMS partner to IP practice I Patent lawyer brings expertise in pharmaceuticals, tech and AI

Powell Gilbert co-founder moves to US firm

14 October 2024 US firm doubles down in Europe with another big name recruit | Tech and life sciences litigation at the UPC a target | Powell will 'always be a friend of the firm’ says ex-colleague Penny Gilbert | Move ends speculation about Powell’s future after August resignation.

More features

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

UPC deals further blow to Dexcom in glucose monitor dispute with Abbott

‘A marathon and a sprint at the same time’: How we won $452m damages